Clinical Trial Update: Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether adding amifostine to radiation therapy for primary prostate cancer is feasible and tolerable, focusing on toxicity outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: University of Arizona | Conditions: Prostate Cancer, Radiation Toxicity | Phase 2 | Status: COMPLETED